+ND Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
RgenixFeb 2021SEC filingmedium confidence
BiotechNew York, US
David Darst(Chief Operating Officer)Shahram Seyedin-Noor(Executive Chairman)Nancy Chang(Director)Isabel Kurth(Vice President - Research)Masoud Tavazoie(Chief Scientific Officer)
Board seatPeter Van Vlasselaer· per SEC Form D · $11M raise · filed Feb 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.